By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350



Drug Discovery

Company News
Xencor Appoints A. Bruce Montgomery, M.D. To Board Of Directors 3/19/2015 6:54:19 AM
Xencor Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Option To Purchase Additional Shares Of Common Stock 3/3/2015 6:46:50 AM
Xencor Prices Public Offering Of Common Stock 2/25/2015 7:25:22 AM
Xencor Announces Proposed Public Offering Of Common Stock 2/24/2015 6:47:15 AM
Xencor Reports Fourth Quarter And Full Year 2014 Financial Results 2/20/2015 8:41:36 AM
Xencor To Host Fourth Quarter And Full Year 2014 Financial Results Webcast And Conference Call 2/12/2015 6:51:39 AM
Xencor To Webcast Presentations At Two Upcoming Conferences In February 2/5/2015 9:02:40 AM
Xencor Reports Top-line XmAb®5871 Phase 1b/2a Results Showing Promising Clinical Activity In Rheumatoid Arthritis 1/29/2015 7:28:44 AM
XencorReports XmAb®7195 Top-line Interim Phase 1a Results Showing Rapid Reduction Of Serum Ige In Healthy Volunteers 1/29/2015 7:26:03 AM
SoCal's Xencor Snags $175 Million+ R&D Pact With Novo Nordisk A/S (NVO) 12/18/2014 6:13:06 AM